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Erythrocyte Transfusion: A Fair Balance
To the Editor:
We read with interest Glance et al.'s paper and the related editorial. 1, 2 Several retrospective studies have already reported an association between perioperative blood transfusion and altered outcome. [3] [4] [5] [6] [7] [8] What is new in the Glance et al. study is that a similar negative association may exist in pre-operative anemic patients having received only one or two units of packed erythrocytes (PRBCs) during the surgical procedure. However, we believe the results of this study should be interpreted with caution for several reasons.
First, as Carson et al. 9 wrote, observational studies are subject to uncontrolled confounding. In fact, patients who receive blood transfusions are probably more severely ill than those who do not receive them, and patients who are more severely ill have more adverse clinical outcomes (death, infection, etc.) than less ill patients. Thus, no matter how refined the adjustment is for differences in illness burden, it is never possible to ensure a complete adjustment for differences between patients receiving and not receiving blood transfusion.
Second, the transfusion trigger that was used in the study population was not specified. Was it a hemoglobin-based transfusion trigger or based on objective indices of oxygen delivery deficiency? 10 -12 PRBC transfusions are administered to increase oxygen transport and restore tissue oxygenation when oxygen demand exceeds supply. 13 The oxygen extraction ratio reflects the adequacy of the cardiorespiratory response of the patient to anemia. Some authors have explored the utility of oxygen extraction ratio for guiding erythrocyte transfusion. 14, 15 Erythrocyte transfusions can also be based on signs and symptoms of impaired global oxygenation with the use of lactate or mixed venous oxygen saturation. The mixed venous oxygen saturation or its surrogate, the central venous oxygen saturation, integrates the relationship between whole-body oxygen uptake and oxygen transport and has been proposed by Vallet et al. as a simple physiologic transfusion trigger. 16 Third, the indication for transfusion was not specified in the study. The reason why some anemic patients were transfused with one or two units while other "similar" anemic patients were not was not explained. Reasons could include several factors such as the importance of blood loss, the hemodynamic stability of the patients, and their underlying pathologies that could by themselves influence the postoperative outcome. To minimize the confounding effect of surgical blood loss on patient outcome, the authors have excluded patients who received four or more PRBC units; however, this effort does not completely eliminate the effect of blood loss on the indication for transfusion. They also attempted to take into account the underlying pathologies of their patients but could not evaluate the effect of these pathologies on the transfusion trigger used by the clinician taking care of the patient.
Fourth, another important point that has not been specified is the etiology of anemia in the patient population. Different etiologies may differentially affect the postoperative outcome. Indeed, Kulier et al. showed that anemic patients have an increased risk of postoperative adverse events, but the extent of preexisting comorbidities substantially affects perioperative anemia tolerance. They recommended that the assessment of blood transfusions should take into account not only the preoperative hemoglobin concentration but also the extent of concomitant risk factors. 17 Finally, the quality of the blood products that were transfused was not described. Were the PRBC units that were transfused leukoreduced? What about the age of the blood transfused? These factors could have affected the known negative association between the transfusion of one or two PRBC units and postoperative morbidity and mortality.
In conclusion, any inappropriate PRBC transfusion should be avoided because the benefit-to-risk ratio of this treatment does not appear favorable for the patient. However, undertransfusion may also be unacceptable because it may expose patients to an increased risk of complications. 18 Distinguishing the effects of PRBC transfusion on patient postoperative outcome definitely requires well-conducted, prospective randomized studies that account for the multiple confounders associated with transfusion practice. 
